Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Vision-related functioning outcomes of dexamethasone intravitreal implant in noninfectious intermediate or posterior uveitis.

Lightman S, Belfort R Jr, Naik RK, Lowder C, Foster CS, Rentz AM, Cui H, Whitcup SM, Kowalski JW, Revicki DA.

Invest Ophthalmol Vis Sci. 2013 Jul 18;54(7):4864-70. doi: 10.1167/iovs.12-10981.

PMID:
23761087
2.

Normative comparison of patient-reported outcomes in patients with noninfectious uveitis.

Naik RK, Rentz AM, Foster CS, Lightman S, Belfort R Jr, Lowder C, Whitcup SM, Kowalski JW, Revicki DA.

JAMA Ophthalmol. 2013 Feb;131(2):219-25. doi: 10.1001/2013.jamaophthalmol.102.

PMID:
23411886
3.

Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis.

Lowder C, Belfort R Jr, Lightman S, Foster CS, Robinson MR, Schiffman RM, Li XY, Cui H, Whitcup SM; Ozurdex HURON Study Group.

Arch Ophthalmol. 2011 May;129(5):545-53. doi: 10.1001/archophthalmol.2010.339. Epub 2011 Jan 10.

PMID:
21220619
4.

Effect of Adalimumab on Visual Functioning in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis in the VISUAL-1 and VISUAL-2 Trials.

Sheppard J, Joshi A, Betts KA, Hudgens S, Tari S, Chen N, Skup M, Dick AD.

JAMA Ophthalmol. 2017 Jun 1;135(6):511-518. doi: 10.1001/jamaophthalmol.2017.0603.

PMID:
28426849
5.

Dexamethasone intravitreal implant in the treatment of persistent uveitic macular edema in the absence of active inflammation.

Cao JH, Mulvahill M, Zhang L, Joondeph BC, Dacey MS.

Ophthalmology. 2014 Oct;121(10):1871-6. doi: 10.1016/j.ophtha.2014.04.012. Epub 2014 Jun 3.

PMID:
24907061
6.

Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.

Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; OZURDEX GENEVA Study Group.

Ophthalmology. 2010 Jun;117(6):1134-1146.e3. doi: 10.1016/j.ophtha.2010.03.032. Epub 2010 Apr 24.

PMID:
20417567
7.

Psychometric evaluation of the National Eye Institute Visual Function Questionnaire and Visual Function Questionnaire Utility Index in patients with non-infectious intermediate and posterior uveitis.

Naik RK, Gries KS, Rentz AM, Kowalski JW, Revicki DA.

Qual Life Res. 2013 Dec;22(10):2801-8. doi: 10.1007/s11136-013-0412-y. Epub 2013 May 5.

PMID:
23645458
8.

Dexamethasone intravitreal implant: an effective adjunctive treatment for recalcitrant noninfectious uveitis.

Miserocchi E, Modorati G, Pastore MR, Bandello F.

Ophthalmologica. 2012;228(4):229-33. doi: 10.1159/000343060. Epub 2012 Oct 3.

PMID:
23038070
9.

[Vision-and health-related quality of life in patients with uveitis].

Zhang J, Yan HG, Chi Y, Guo CY, Yang L.

Zhonghua Yan Ke Za Zhi. 2016 Jun 11;52(6):429-36. doi: 10.3760/cma.j.issn.0412-4081.2016.06.007. Chinese.

PMID:
27373571
10.

Dexamethasone intravitreal implant (Ozurdex®) for pediatric uveitis.

Sella R, Oray M, Friling R, Umar L, Tugal-Tutkun I, Kramer M.

Graefes Arch Clin Exp Ophthalmol. 2015 Oct;253(10):1777-82. doi: 10.1007/s00417-015-3124-x. Epub 2015 Jul 31.

PMID:
26228441
11.

Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis.

Pavesio C, Zierhut M, Bairi K, Comstock TL, Usner DW; Fluocinolone Acetonide Study Group.

Ophthalmology. 2010 Mar;117(3):567-75, 575.e1. doi: 10.1016/j.ophtha.2009.11.027. Epub 2010 Jan 15.

PMID:
20079922
12.

Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.

Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM; Ozurdex GENEVA Study Group, Li J.

Ophthalmology. 2011 Dec;118(12):2453-60. doi: 10.1016/j.ophtha.2011.05.014. Epub 2011 Jul 20.

PMID:
21764136
13.

Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.

Jaffe GJ, Martin D, Callanan D, Pearson PA, Levy B, Comstock T; Fluocinolone Acetonide Uveitis Study Group.

Ophthalmology. 2006 Jun;113(6):1020-7. Epub 2006 May 9.

PMID:
16690128
14.

Longitudinal Vision-Related Quality of Life for Patients with Noninfectious Uveitis Treated with Fluocinolone Acetonide Implant or Systemic Corticosteroid Therapy.

Sugar EA, Venugopal V, Thorne JE, Frick KD, Holland GN, Wang RC, Almanzor R, Jabs DA, Holbrook JT; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group.

Ophthalmology. 2017 Jun 14. pii: S0161-6420(16)32265-5. doi: 10.1016/j.ophtha.2017.05.015. [Epub ahead of print]

PMID:
28624167
15.

Vision- and health-related quality of life in patients with Behçet uveitis.

Onal S, Savar F, Akman M, Kazokoglu H.

Arch Ophthalmol. 2010 Oct;128(10):1265-71. doi: 10.1001/archophthalmol.2010.209.

PMID:
20937995
16.

Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials.

Suñer IJ, Kokame GT, Yu E, Ward J, Dolan C, Bressler NM.

Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3629-35. doi: 10.1167/iovs.08-3225. Epub 2009 Feb 28.

PMID:
19255158
17.

Treatment of intractable posterior uveitis in pediatric patients with the fluocinolone acetonide intravitreal implant (Retisert).

Patel CC, Mandava N, Oliver SC, Braverman R, Quiroz-Mercado H, Olson JL.

Retina. 2012 Mar;32(3):537-42. doi: 10.1097/IAE.0b013e31822058bb.

PMID:
21963487
18.

Vision-specific health-related quality of life in age-related maculopathy patients presenting for low vision services.

Scilley K, DeCarlo DK, Wells J, Owsley C.

Ophthalmic Epidemiol. 2004 Apr;11(2):131-46.

PMID:
15255028
19.

Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.

Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Louis TA, Sugar EA, Thorne JE.

Ophthalmology. 2011 Oct;118(10):1916-26. doi: 10.1016/j.ophtha.2011.07.027. Epub 2011 Aug 15. Erratum in: Ophthalmology. 2012 Feb;119(2):212.

20.

Treatment of experimental anterior and intermediate uveitis by a dexamethasone intravitreal implant.

Ghosn CR, Li Y, Orilla WC, Lin T, Wheeler L, Burke JA, Robinson MR, Whitcup SM.

Invest Ophthalmol Vis Sci. 2011 May 2;52(6):2917-23. doi: 10.1167/iovs.10-5939.

PMID:
21273539

Supplemental Content

Support Center